Overview

A Phase II Clinical Study of Surufatinib Combined With Sintilimab in the Treatment of Advanced Gastric Cancer

Status:
Not yet recruiting
Trial end date:
2025-03-31
Target enrollment:
Participant gender:
Summary
The efficacy and safety of the use of Surufatinib in combination with Sintilimab.
Phase:
Phase 2
Details
Lead Sponsor:
Sun Yat-sen University